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Objective: To evaluate the efﬁcacy of hysteroscopic myomectomy using the Lin dissecting loop and Lin
myoma graspers to remove myoma in a single procedure.
Materials and Methods: This was a retrospective study performed in the gynecologic department of
a general hospital. A total of 1569 women with submucous myoma or symptomatic intramural myoma
underwent one-step resectoscopic myomectomy using Lin dissecting loop and Lin myoma graspers.
Results: Of the 1569 patients, pedunculated submucous myoma, sessile submucous myoma, and intra-
mural myoma were diagnosed in 943, 608, and 19 patients, respectively. The patients’ median age was
38.6 years (range 19e59 years). The operating time was between 4 minutes and 147 minutes (mean
30.6 18.2 minutes). The specimen weighed from 0.1 g to 380 g (mean 19.9 21.4 g). Two uterine
perforations caused by myoma graspers were encountered. No ﬂuid complications were experienced.
Almost all of the patients had improvement of symptoms. Long-term follow-up revealed ﬁve cases of
abdominal total hysterectomy, one case of abdominal myomectomy, 21 cases of rehysteroscopic opera-
tion, 59 cases of normal spontaneous delivery, 36 cases of cesarean section, ﬁve cases of ongoing
pregnancy, and one case of spontaneous abortion. No case of uterine rupture was encountered. There was
one case of placenta accreta that required hysterectomy.
Conclusion: Using our technique and instruments, it is possible to remove a myoma in a single procedure
safely and effectively. This surgical method can also preserve more endometrium, cause less injury to the
muscle layer, and prevent ﬂuid complications.
Copyright  2012, The Asia-Paciﬁc Association for Gynecologic Endoscopy and Minimally Invasive
Therapy. Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Submucous myoma, regardless of its size, frequently causes
menorrhagia andmetrorrhagia, and sometimes results in infertility.
To date, hysteroscopic myomectomy has been regarded as the
standard procedure to treat these myomas.1,2 Usually a resecto-
scope is used to shave the myoma from its most protruded area in
the uterine cavity. Hence, the degree of its uterine protrusion
determines the feasibility of this procedure. In the case of a broad-
based, deeply invaded submucous myoma, also termed a sessile
myoma, it is rather difﬁcult to remove the myoma completely inand Gynecology, Kawasaki
, Kawasaki 210-0013, Japan.
ia-PaciﬁcAssociation forGynecologicEnone hysteroscopic procedure. Two or more steps are usually
required. In 2000, we published our technique of one-step hys-
teroscopicmyomectomy3which is the same as that used to perform
an abdominal or laparoscopic myomectomy. After that, several Lin
instruments were designed to facilitate the operation. We present
our experience of how to remove a submucous myoma completely
in a single procedure using these instruments.
Materials and methods
FromOctober 2003 to December 2011,1569 consecutive patients
who had been referred to our gynecologic department and satisﬁed
the following surgical indications were enrolled in the study.
Indications for hysteroscopic myomectomy:
1. Uterine size 12 weeks’ gestational size; cavity length <12 cm.doscopyandMinimally InvasiveTherapy.PublishedbyElsevierTaiwanLLC.All rightsreserved.
Fig. 2. Sonohysterography performed immediately after diagnostic hysteroscopy to
measure the size of the submucous myoma (34.5  35.9 mm), serosa-myoma thickness
(7.5 mm), and the uterus (65.4  62.6 mm).
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protrusion >50%).
3. The largest diameter of the myoma 40 mm in diameter (if
intrauterine protrusion 50%).
4. Symptomatic intramural myoma 30 mm in diameter.
5. Serosa-myoma thickness (SMT) 5 mm.
6. No existence of uterine malignancy.
Preoperative assessments
Ofﬁce hysteroscopy
A 3.1 mm ﬂexible hysteroscope (Olympus Optical Co., Tokyo,
Japan) was used without cervical dilation or anesthesia to conﬁrm
the location, size and the number of the myoma. If necessary,
a directed biopsy was done to rule out endometrial malignancy.
According to our classiﬁcation, the ratio of intrauterine protrusion
of the myoma was estimated (Fig. 1). Pedunculated submucous
myoma is deﬁned to the myoma with the ratio of intrauterine
protrusion larger than 50%. Sessile submucous myoma is deﬁned to
its protrusion ratio smaller or equal to 50%.
Ultrasound examinations
Immediately after diagnostic hysteroscopy both abdominal and
vaginal ultrasonographies (sonohysterography)4 were done to
evaluate the size of the uterus, the number, location and size of the
myoma, and the SMT5 (Fig. 2).
Magnetic resonance imaging (MRI)
MRI, which is now a very popular examination in Japan, was not
used as a routine examination. It was done for those patients with
multiple myomas or suspicion of other pathologic lesions such as
uterine sarcoma. (Fig. 3)
Pap smear and endometrial cytologic or pathologic examination
To exclude uterine malignancy, these examinations were done
on the patient’s ﬁrst visit if she had not been already received the
examinations yet.
Preoperative treatment with gonadotropin-releasing hormone
analogue
Gonadotropin-releasing hormone (GnRH) analogue6 was used
mainly for those patients with a myoma larger than 4 cm.
1. Myoma 5 cm in diameter. GnRH analogue depot-leuprolide
acetate 1.88 mg (Lupron; Takeda Chemical Industries, Osaka,
Japan) three doses (1 month/one injection) were prescribed.Fig. 1. Intrauterine protrusion of submucous myoma.2. 5 cm>myoma4 cm in diameter. Two doses of GnRH analogue
Lupron 1.88 were used.
3. No treatment for myoma <4 cm.
Cervical priming
A piece of laminaria tent (Nippon Laminaria Co., Gifu, Japan) was
inserted into the uterine cavity the night before the surgery to
soften and dilate the cervix.7 If the insertion of laminaria tent was
difﬁcult, a piece of Lamicel (Medtronic Xomed, Inc., Jacksonville, FL,
USA) was used instead.
Usually, laryngeal mask anesthesia was used. All procedures
were monitored by concomitant abdominal ultrasonography.8
Instrumentation
The following instrumentswere used during the procedures: 22-
French resectoscope (Kar Storz Co., Tuttlingen, Germany); Lin dis-
secting loop (Kar Storz Co.) (Fig. 4); Lin curved tenaculum (AtomCo.,
Tokyo, Japan); Lin myoma graspers (Fig. 5) used under ultrasound
guidance; Lin self-retainer for holding the abdominal ultrasound
probe.
Distending medium
The 3-L distending media (3% sorbitol solution; Baxter Co.,
Singapore, Japan) is delivered to the uterine cavity by simple
gravity ﬂow from approximately 100 cm above the patient. This
process resulted in an intrauterine pressure of 72 mmHg as
measured by the HP Component Monitoring System3 (Agilent
Technologies Co., Palo Alto, CA, USA). The ﬂuid outﬂow was
retrieved and the amount of deﬁciency was calculated.9 Our limi-
tation of ﬂuid deﬁcit was 1000 mL.
Techniques of resectoscopic myomectomy
1) Cutting the myoma pedicle (Figs. 6e9). We started using a 22-
French resectoscope equipped with a Lin dissecting loop to cut
into the cleavage between the myoma and the myometrium.
After opening the space, the irrigating ﬂuid ﬂew into the
cleavage, causing water dissection, and the space of the
Fig. 3. Magnetic resonance imaging of a submucous myoma measuring approximately 61.7  57.0  57.3 mm with 10% intrauterine protrusion: (A) coronal view; (B) axial view.
C ¼ cavity; M ¼ myoma.
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the myometrium by cutting the tissue in the cleavage and
pushing the myoma into the uterine cavity using a Lin dis-
secting loop. We followed the same principles of dissecting the
myoma from the muscular layer as if the myomectomy was
performed by scissors in an abdominal procedure. This proce-
dure was done from both sides of the myoma to dissect and to
move the myoma away from the myometrium to prevent
potential uterine perforation.
2) Cutting the myoma body (Figs. 10 and 11). The Lin dissecting
loop was changed into a conventional cutting loop to shave the
myoma from the dissected pedicle to create a space to allow
a Lin myoma grasper (Atom Co.) to hold the myoma. The
surface of the myoma was shaved into an uneven surface that
enabled a grasper to hold the myoma ﬁrmly. Then the myoma
was pulled farther into the intrauterine cavity. Extracting and
rotating the myoma resulted in complete separation of the
myoma from the muscular layer. Then, using a cutting loop, the
myoma was cut and divided horizontally and vertically into
quadrants by what we call a cross resection technique. TheFig. 4. A conventional cutting loop, zero-degree cutting loop, and a Lin dissecting loop,
seen from above.myoma was torn and removed by the grasper. All the grasper
procedures were done under ultrasound guidance.
Postoperative management
After the procedure, if continuous bleeding occurred, a 24- or
26-French balloon catheter (Norta, Beiersdorf, Germany) was
introduced into the uterine cavity and the balloonwas inﬂatedwith
10-15 mL normal saline to compress bleeding vessels. If the
bleeding did not stop, the amount of balloon ﬂuid was increased or
the external cervical oriﬁce was closed with an absorbable thread
(Vicryl rapide; Johnson & Johnson Co., Tokyo, Japan). The intra-
uterine balloon and the cervical suture were removed on the ﬁrst
day after the surgery. A prophylactic oral antibiotic (Pansporin),
1000 mg, was given for 4 days.
For those patients who desire to bear children, an intrauterine
device (IUD) (FD-1; Fuji latex Co., Tochigi, Japan) was placed after
the procedure to prevent intrauterine adhesions. Conjugated
estrogen 1.875 mg/day for 10-14 days was given to those patientsFig. 5. A Lin myoma grasper.
Fig. 6. Steps of resectoscopic myomectomy. Cut from the left side to get into the plane of the cleavage between the myoma and the myometrium using the Lin dissecting loop.
Dissect the myoma away from the myometrium. Then, the next step is to cut from the right side and dissect the myoma.
Fig. 7. The Lin loop is used to cut the junction between the myoma and the
myometrium. Fig. 8. A cut is made into the plane of the cleavage.
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Fig. 9. The myoma is dissected away from the myometrium.
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defect after resection. One month later, early second-look hys-
teroscopy was performed. If no abnormal ﬁnding was found, the
IUD was removed. The patients were allowed to conceive 2 monthsFig. 10. Additional steps of resectoscopic myomectomy, continued from Fig. 6: Cut the myom
myoma with a Lin myoma grasper. Rotate the myoma to separate it from the muscle layer.after the surgery. Vaginal delivery was the choice if there were no
other indications for cesarean section.
All of the other patients returned for examination 1 month after
the surgery. Because more than 90% of the patients were referred
from other hospitals or local practitioners, we asked the patients to
follow up with their own doctors. If any problem occurred, the
patients will be sent back again for evaluation.
Results
Of the 1569 patients, pedunculated submucous myoma, sessile
submucous myoma, and intramural myomawere diagnosed in 943,
608, and 19 patients, respectively. The patient’s median age was
38.6 years (range, 19-59 years). The surgical time was between
4 minutes and 147 minutes (mean 30.6  18.2 minutes). The
specimen weighed from 0.1 g to 380 g (mean 19.9  21.7 g). The
380 g specimen was removed from a cervical myoma pretreated
with selective arterial embolization. To prevent intrauterine
adhesions, an IUD (FD-1) was placed in 1028 patients (65.5%). To
stop bleeding, balloon compression was performed in 96 patients
(6.1%) and balloon compression combined with closure of the
external oriﬁce in 20 patients (1.3%). Two cases of uterine perfo-
ration caused by the myoma grasper were encountered. Lapa-
rotomy was used to repair the wound. No hypernatremia was
found. Almost all of the patients had improvement of symptoms.
Long-term follow-up revealed ﬁve cases of abdominal total
hysterectomy, one case of abdominal myomectomy, and 21 cases of
rehysteroscopic operation. The pregnancy outcome was 60 cases ofa body to divide it into quadrants with a conventional cutting loop. Pull and extract the
Tear and remove the myoma.
Fig. 11. A conventional cutting loop is used to shave the myoma body.
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cases of ongoing pregnancy, and one case of spontaneous abortion.
No case of uterine rupture was encountered. A case of placenta
accreta that required hysterectomy was experienced.
Fig. 3 is an MRI of a 26-year-old woman, gravida 0 para 0. She
underwent hysteroscopic myomectomy twice in our hospital, at
ages 18 years and 24 years. During the ﬁrst procedure, a peduncu-
lated submucous myoma weighing 42 g was removed. During the
second procedure, a pedunculated submucous myoma and 18
intramural myomas with a total weight of 20 g were removed. Two
years after the second surgery, the patient returned with the chief
complaint of heavy menstruation. The MRI showed a submucous
myoma that measured approximately 61.7  57.0  57.3 mm with
10% intrauterine protrusion. After pretreatment with three doses of
leuprolide acetate 1.88 mg, the patient underwent hysteroscopic
myomectomy. A 90 gmyomawas completely removed. The surgery
timewas 56minutes. Eighteen months later, the patient conceived;
a 2395 g infant was safely delivered by cesarean section at 36
weeks’ gestation.Discussion
There are three factors that signiﬁcantly determine the feasi-
bility of hysteroscopic myomectomy: degree of myoma protrusion
into the uterine cavity, and size and consistency of the myoma.10
The conventional technique of resectoscopic myomectomy is to
use a resectoscope cutting loop to shave the myoma adjacent to the
level of the endometrium. Usually dissection below the level of the
endometrial cavity is prohibited because of the risk of hemorrhage,
perforation, and ﬂuid overload. In case of deeply invasive sub-
mucous myoma, two or more procedures are often required.
Symptomatic intramural myoma, of course, is unable to be
removed. Using our dissection technique, the myoma is dissected
away from the myometrium ﬁrst. Then the myoma is pulled,
rotated, and torn using a Lin myoma forceps that enables complete
removal in one procedure. Even a symptomatic intramural myoma,
if the size is smaller or equal to 3 cm and the location can be
navigated by the concomitant ultrasonography, can be removed
completely with our technique.Instead of European Society for Gynaecological Endoscopy
(ESGE) classiﬁcation of submucous myoma,11 a widely used system,
we use ratio classiﬁcation, which describes the degree of the
myoma protruding into the uterine cavity and the concept of SMT
to predict the perioperative outcomes. With ESGE classiﬁcation,
perioperative outcome cannot be compared among patients of the
same type. For example, there are two cases of submucous myoma
with the same size and of the same type (3 cm in diameter and type
II). One is a 40% intrauterine protrusion and the other is a 10%
intrauterine protrusion. To compare the feasibility of surgery, it is
obvious that the submucous myoma with 40% intrauterine
protrusion is easier to remove. However, with ESGE classiﬁcation
no information can be obtained.
Our purposes for preoperative treatment with GnRH analogue
are to decrease myoma volume, increase hemoglobin, and decrease
blood loss during the operation. However, long-term treatment
with GnRH analogue will cause loss of plane of cleavage and make
myoma dissection more difﬁcult. Therefore, we restrict the use of
GnRH analogue to two or three doses and it is our belief that the
dissection of myoma was less difﬁcult.
Hysteroscopic myoma dissection is different from a laparoscopic
or abdominal dissection. During a hysteroscopic dissection, there is
another assisted power coming fromwater dissection, which is not
used during the laparoscopic or abdominal approach.
To prevent cervical laceration that may be caused by the myoma
grasper, cervical priming is very important, especially for nullipa-
rous women who received GnRH analogue treatment. Several
methods, including use of the laminaria tent, Lamicel, Dilapan, and
Misoprostol, have been reported.12 We had many opportunities to
perform hysteroscopic myomectomy in other areas where the
laminaria tent was not available. By comparison of different
methods we conclude that the laminaria tent is the best method for
cervical priming.
Starting in 1985, we have encountered more than 4000 cases of
hysteroscopic myomectomy. All the procedures were done by the
same surgeon. By comparison between the periods of using and
without using Lin graspers (unpublished data), we conclude that
there are three advantages of using myoma graspers: (1) Shortened
surgical time. (2) Avoidance of ﬂuid complications.13,14 The surgical
time to use the resectoscope is shortened. As a consequence, the
amount of irrigating ﬂuid can be reduced and the potential risk of
ﬂuid complications can be avoided. (3) Increased intracavitary
protrusion of the myoma by means of grasping and extracting the
myoma.
Use of coagulation current to stop uterine bleeding at the end of
the procedure is the most popular method. However, profuse and
extended bleeding may cause hyponatremia. A 24-French or 26-
French balloon catheter can be used to compress the area of bleeding.
Under ultrasoundmonitoring the balloon is inﬂated to the size of the
preoperative submucous myoma. If the bleeding does not stop, the
volume of balloon ﬂuid is increased, which usually can stop the
bleeding. If this step does not work or the bleeding comes from
the vessels near the internal oriﬁce, often a suture to close the
external oriﬁce cansolve the problem. In case of prolapsed sub-
mucous myoma, the external cervical oriﬁce is very wide and the
balloonwill easily slip into the vagina. Closure of the external cervical
oriﬁce is a good way to keep the balloon in the uterine cavity.
In case of vaginal bleeding with uterine perforation,15 vaso-
pressin injection is the most effective method to stop the bleeding.
Using balloon compression, the balloonmay be introduced through
the perforated wound into the abdominal cavity.
Two cases of uterine perforation caused by myoma grasper were
experienced. One was a nulliparous patient with a small and hard
cervix; a laminaria tent could not be inserted before the surgery. The
other perforation occurred because of attempts to remove a small
B.-L. Lin et al. / Gynecology and Minimally Invasive Therapy 1 (2012) 27e33 33intramuralmyomawithagrasperafter removalofa105g largemyoma.
No perforationwas encountered during the dissection of the myoma.
To ensure the safety of the operation, a concomitant ultraso-
nography was used to monitor the entire procedure. However, an
assistant was needed to hold the ultrasound probe. To solve this
problem, we developed a Lin self-retainer that can be used to hold
an abdominal ultrasound probe without an assistant.
Conclusion
The advantages of our technique are to preserve more endo-
metrium, lessen injury to the muscle layer, prevent ﬂuid compli-
cations, and enhance a complete one-step removal of the myoma.
Our results proved that our technique is a safe and efﬁcient method
for the treatment of submucous myoma.
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